|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
A multicentre, multinational, randomizedm Double-Blind, Placebo Controlled, crossover trial to evaluate efficacy and safety of Fentanyl TAIFUN ® treatment after titrated dose administration for breakthrough pain in cancer patients on maintenance opioid therapy
|
|
|
Disease Condition |
Breakthrough Pain in late stage cancer patients
|
|
|
Phase of Trial |
Phase-3
|
Discipline |
Oncology
|
|
|
Start date of Trial |
8/1/2009
|
Closing Date of Trial |
2/1/2011
|
|
|
|